Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

33
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
33
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

32
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
32
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

865
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
865
Lipid Absorption01:24

Lipid Absorption

708
Dietary triglycerides from chyme in the duodenum are mixed with bile salts produced by the liver to emulsify fats. As a result, large droplets are broken down into smaller ones, increasing the surface area for enzymatic action. Once emulsified, pancreatic lipases hydrolyze the triglycerides into free fatty acids and monoglycerides.
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
708
Operant Conditioning Intervention01:24

Operant Conditioning Intervention

112
Operant conditioning serves as a foundational principle in therapeutic interventions aimed at modifying maladaptive behaviors. Central to this approach is the notion that behaviors, both adaptive and maladaptive, are learned through reinforcement. By analyzing the environmental factors that reinforce problematic behaviors, clinicians can design interventions to weaken these reinforcements and replace maladaptive behaviors with healthier alternatives.
In operant conditioning, behaviors that are...
112
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

2.4K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
2.4K

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Harnessing Large-Scale Multi-Omics Data for Risk Prediction and Deep Phenotyping of Valvular Heart Diseases in the General Population.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Prenatal Acetaminophen (Paracetamol) Use and the Risk of Autism and/or Attention-Deficit/Hyperactivity Disorder Among Sibling-Matched Cohorts.

JAMA internal medicine·2026
Same author

Cardiovascular outcomes and safety associated with statin therapy for primary prevention in older adults with type 2 diabetes: A target trial emulation study.

PLoS medicine·2026
Same author

Identifying druggable proteins of the association of chronotype on breast cancer using Mendelian randomization.

Communications medicine·2026
Same author

Association of Reduction in Continuity of Care During COVID-19 Pandemic With Cardiovascular Diseases, Kidney Failure and All-Cause Mortality for People With Diabetes: A Cohort Study in Hong Kong.

Diabetes, obesity & metabolism·2026
Same author

Authors' reply: Myasthenia gravis following the initiation of statin therapy.

Journal of internal medicine·2026

Video Experimental Relacionado

Updated: Sep 10, 2025

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF
03:42

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF

Published on: March 29, 2024

1.7K

Optimizar la prevención de enfermedades a largo plazo con aprendizaje de refuerzo: un marco para el control de

Yekai Zhou1,2,3, Ruibang Luo4,5,6, Joseph Edgar Blais7

  • 1Department of Computer Science, School of Computing and Data Science, The University of Hong Kong, Hong Kong SAR, China.

NPJ digital medicine
|August 27, 2025
PubMed
Resumen

Duramax, un nuevo marco de IA, optimiza la prevención de enfermedades crónicas a largo plazo mediante el análisis de datos del mundo real. Mejora las estrategias de reducción del riesgo de enfermedades cardiovasculares (ECV), ofreciendo recomendaciones personalizadas y transparentes.

Más Videos Relacionados

A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM
13:54

A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM

Published on: August 18, 2023

4.9K
A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
10:56

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes

Published on: September 15, 2018

8.2K

Videos de Experimentos Relacionados

Last Updated: Sep 10, 2025

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF
03:42

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF

Published on: March 29, 2024

1.7K
A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM
13:54

A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM

Published on: August 18, 2023

4.9K
A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
10:56

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes

Published on: September 15, 2018

8.2K

Área de la Ciencia:

  • Medicina computacional
  • Inteligencia artificial en la salud
  • Cardiología preventiva

Sus antecedentes:

  • La prevención de enfermedades crónicas requiere estrategias adaptativas más allá de los objetivos de tratamiento a corto plazo.
  • Los enfoques actuales pueden carecer de información completa sobre las trayectorias de supervivencia a largo plazo de los pacientes.
  • La medicina personalizada requiere herramientas analíticas avanzadas para optimizar la atención preventiva.

Objetivo del estudio:

  • Presentar Duramax, un marco de aprendizaje de refuerzo basado en la evidencia.
  • Optimizar las estrategias preventivas a largo plazo para las enfermedades crónicas, centrándose en las enfermedades cardiovasculares (ECV).
  • Mejorar la prevención personalizada de enfermedades mediante el análisis computacional de los registros de salud.

Principales métodos:

  • Desarrolló Duramax, un marco de aprendizaje de refuerzo entrenado en datos de tratamiento del mundo real.
  • Se utilizaron extensos conjuntos de datos que abarcan más de 200 fármacos modificadores de lípidos y 3,6 millones de meses de tratamiento.
  • Se validó el rendimiento de Duramax en una cohorte independiente con más de 29,7 millones de meses de tratamiento.

Principales resultados:

  • Duramax logró un valor de política de 93, superando significativamente a los médicos (valor de 68).
  • La alineación con las sugerencias de Duramax redujo el riesgo de ECV en un 6% en la práctica clínica.
  • El análisis post hoc confirmó que el proceso de toma de decisiones de Duramax era transparente y razonable.

Conclusiones:

  • Duramax demuestra un rendimiento superior en la optimización de estrategias preventivas a largo plazo para las enfermedades cardiovasculares.
  • El análisis computacional personalizado de los registros de salud permite una prevención personalizada de enfermedades altamente matizada.
  • Los marcos impulsados por IA pueden mejorar significativamente los resultados de los pacientes en el manejo de enfermedades crónicas.